Secondary Progressive Multiple Sclerosis

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

Functional Outcomes From Diets in Multiple Sclerosis

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme

Metformin Treatment in Progressive Multiple Sclerosis

Simvastatin in Secondary Progressive Multiple Sclerosis

Cladribine Tablets as an Exit Therapy Strategy

ACTH in Progressive Forms of MS

A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis

Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Novel Imaging Markers in SPMS